These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6818145)

  • 1. Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis.
    Chinn RY; Diamond RD
    Infect Immun; 1982 Dec; 38(3):1123-9. PubMed ID: 6818145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxidative and nonoxidative microbicidal products of human neutrophils in vitro.
    Diamond RD; Clark RA
    Infect Immun; 1982 Nov; 38(2):487-95. PubMed ID: 6292103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte-mediated damage to Rhizopus oryzae hyphae in vitro.
    Diamond RD; Haudenschild CC; Erickson NF
    Infect Immun; 1982 Oct; 38(1):292-7. PubMed ID: 7141693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil chemotactic responses induced by fresh and swollen Rhizopus oryzae spores and Aspergillus fumigatus conidia.
    Waldorf AR; Diamond RD
    Infect Immun; 1985 May; 48(2):458-63. PubMed ID: 3157647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis.
    Diamond RD; Krzesicki R; Epstein B; Jao W
    Am J Pathol; 1978 May; 91(2):313-28. PubMed ID: 347942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp.
    Simitsopoulou M; Georgiadou E; Walsh TJ; Roilides E
    Med Mycol; 2010 Aug; 48(5):720-4. PubMed ID: 20100138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucorales species activation of a serum leukotactic factor.
    Marx RS; Forsyth KR; Hentz SK
    Infect Immun; 1982 Dec; 38(3):1217-22. PubMed ID: 6759409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary defense mechanisms against opportunistic fungal pathogens.
    Waldorf AR
    Immunol Ser; 1989; 47():243-71. PubMed ID: 2490078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil chemotaxis in patients with Staphylococcus aureus furunculosis.
    Cates KL; Quie PG
    Infect Immun; 1979 Dec; 26(3):1004-8. PubMed ID: 393626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability.
    Artis WM; Fountain JA; Delcher HK; Jones HE
    Diabetes; 1982 Dec; 31(12):1109-14. PubMed ID: 6816646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro.
    Diamond RD; Clark RA; Haudenschild CC
    J Clin Invest; 1980 Nov; 66(5):908-17. PubMed ID: 6253527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon- gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes.
    Gil-Lamaignere C; Simitsopoulou M; Roilides E; Maloukou A; Winn RM; Walsh TJ
    J Infect Dis; 2005 Apr; 191(7):1180-7. PubMed ID: 15747255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of two neutrophil chemotactic peptides produced by porcine alveolar macrophages.
    Goodman RB; Forstrom JW; Osborn SG; Chi EY; Martin TR
    J Biol Chem; 1991 May; 266(13):8455-63. PubMed ID: 1850745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of neutrophil chemotactic factors from gastric tissue. Initial biochemical characterization.
    Kozol RA; Downes RJ; Kreutzer DL; Wentzel S; Rossomando E; Elgebaly SA
    Dig Dis Sci; 1989 May; 34(5):681-7. PubMed ID: 2653743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative comparisons of various biological responses of neutrophils to different active and inactive chemotactic factors.
    Kreutzer DL; O'Flaherty JT; Orr W; Showell HJ; Ward PA; Becker EL
    Immunopharmacology; 1978 Dec; 1(1):39-47. PubMed ID: 45788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of short-chain fatty acids secreted by Candida albicans hyphae induce neutrophil chemotaxis via free fatty acid receptor 2.
    Khamzeh A; Dahlstrand Rudin A; Venkatakrishnan V; Stylianou M; Sanchez Klose FP; Urban CF; Björnsdottir H; Bylund J; Christenson K
    J Leukoc Biol; 2024 Feb; 115(3):536-546. PubMed ID: 37992073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in chemotactic factor-induced responses of neutrophils and monocytes from chronic dialysis patients.
    Lewis SL; Van Epps DE; Chenoweth DE
    Clin Nephrol; 1988 Aug; 30(2):63-72. PubMed ID: 2846218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of chemotactic factors by veins during preparation for arterial bypass.
    Ruby ST; Allam ME; Gallo MA; Barth S; Elgebaly SA
    Arch Surg; 1990 Apr; 125(4):481-4. PubMed ID: 2181974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotaxis of radiolabeled equine neutrophils.
    Camp CJ; Leid RW
    Am J Vet Res; 1982 Mar; 43(3):397-401. PubMed ID: 7073055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of leukocyte chemotaxis by factor in alloxan-induced diabetic rat plasma.
    Pereira MA; Sannomiya P; Leme JG
    Diabetes; 1987 Nov; 36(11):1307-14. PubMed ID: 3666321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.